Axonal neuropathy and hearing loss associated with alpha interferon treatment in chronic hepatitis B: A case report

Turkish Journal of Gastroenterology

Volumn 15, Issue 2, 2004, Pages 97-99

  Tunca, Ayçe ^a,b   Erbayrak, Mustafa ^a   Aytaç, Şirin ^a   Türkay, Cansel ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b FATIH UNIVERSITY   (Turkey)

Author keywords

Axonal neuropathy; Hearing loss; Interferon

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; LAMIVUDINE; RAMIPRIL;

ADULT; ANAMNESIS; ARTICLE; AUTOIMMUNITY; CASE REPORT; CHRONIC HEPATITIS; ELECTRONEUROGRAPHY; FEMALE; GAIT DISORDER; HEARING LOSS; HEPATITIS B; HUMAN; HYPERTENSION; NERVE FIBER; NEUROLOGIC EXAMINATION; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION DEAFNESS; PURE TONE AUDIOMETRY; TINNITUS;

ANTINEOPLASTIC AGENTS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; AXONS; FEMALE; HEARING LOSS, SENSORINEURAL; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MIDDLE AGED; POLYNEUROPATHIES;

EID: 3943097437     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. th ed. Philadelphia: W.B. Saunders, 1998; 1141-2.
2. Cudillo L, Cantonetti M, Venditti A, et al. Peripheral polyneuropathy during treatment with alpha-2 interferon. Haematologica 1990; 75: 485-6.
3. Sakajiri K, Takamori M. Multiple mononeuropathy during recombinant interferon alpha 2a therapy for chronic hepatitis C. Rinsho Shinkeigaku 1992; 32: 1041-3.
4. Rutkove SB. An unusual axonal polyneuropathy induced by low-dose interferon alpha-2a. Arch Neurol 1997; 54: 907-8.
5. Uoshima N, Akaogi T, Hayashi H, et al. Development of cryoglobulinemia and polyneuropathy in a chronic myeloid leukemia patient during interferon-alpha treatment. Rinsho Ketsueki 1999; 40: 324-9.
6. Mellgren SI. Alpha-interferon therapy and peripheral neuropathy. Pediatr Hematol Oncol 1999; 16: 499-500. Comment on: Pediatr Hematol Oncol 1999; 16: 557-60.
7. Mellgren SI. Alpha-interferon therapy and peripheral neuropathy. Pediatr Hematol Oncol 1999; 16: 499-500. Comment on: Pediatr Hematol Oncol 1999; 16: 557-60.
8. Kanda Y, Shigeno K, Matsuo H, et al. Interferon-induced sudden hearing loss. Audiology 1995; 34: 98-102.
9. Kanda y, Shigeno K, Kinoshita N, et al. Sudden hearing loss associated with interferon. Lancet 1994; 343: 1134-5.
10. Cadoni G, Marinelli L, De Santis A, et al. Sudden hearing loss in a patient hepatitis C virus (HCV) positive on therapy with alpha-interferon: a possible autoimmune-microvascular pathogenesis. J Laryngol Otol 1998; 112: 962-3.
11. Cole RR, Jahrsdoerfer RA. Sudden hearing loss: an update. Am J Otol 1988; 9: 211-5.
12. Ghilardi G, Gonvers J-J, So A. Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection. Br J Rheumatol 1998; 37: 1349-51.
13. Tambini R, Quattrini A, Fracassetti O, Nemni R. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C. J Rheumatol 1997; 24: 1656.
14. La Civita L, Pasero GG, Ferri C. Drs. La Civita, Pasero, and Ferri reply. To the Editor. J Rheumatol 1997; 24: 1656-7.
15. Meriggioli MN. Rowin J. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon. Muscle Nerve 2000; 433-5.
16. Harfat B, Hudlestone JR, Casali P, et al. Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis. J Immunol 1981; 127: 2146-50.
17. Scultz RM, Papamat JD, Chirgos MA. Interferon: an inducer of macrophage activation by polyanions. Science 1997; 197: 674-6.
18. Schattner A. Interferon and autoimmunity. Am J Med Sci 1988; 295: 532-44.